SECTION: NM NUMBER: 20. HENRY FORD HOSPITAL DETROIT, MICHIGAN TITLE: GLYCEMIC CONTROL INTENSIVE CARE PROTOCOL UNIT: All ICUs
|
|
- Asher Brown
- 8 years ago
- Views:
Transcription
1 CLINICALPROTOCOL MULTIDISCIPLINARY SECTION: NM NUMBER: 2 HENRY FORD HOSPITAL DETROIT, MICHIGAN TITLE: GLYCEMIC CONTROL INTENSIVE CARE PROTOCOL UNIT: All ICUs APPROVED: 3/3 REVIEWED: REVISED: 12/3, 5/, /, /5, 3/, 11/ POLICY: The RN will administer insulin according to the Intensive Care Glycemic Control Protocol to all adult ICU patients if the responsible physician prescribes ICU Glycemic Control Protocol or per protocol and the patient is in an adult ICU. All insulin will be administered per protocol subsection entitled administration. CONTENT STATEMENTS: Goal: To attain a glucose level between and 1 mg/dl. Contraindications to the Intensive Care Glycemic Control Protocol: 1. DKA Diabetic KetoAcidosis 2. History of end stage renal disease requiring peritoneal dialysis with IcoDextrin (Extraneal ) IcoDextrin interferes with the Accu-Chek glucose meter causing a falsely elevated glucose level. For patients with end stage renal disease with a history of renal replacement therapy via peritoneal dialysis the fingerstick glucose measurement will be compared to a simultaneously measured serum glucose (measured by the hospital laboratory) before the ICU Glycemic Control Protocol is started. This accuracy check is done to assess a history of peritoneal dialysis with IcoDextrin (Extraneal ). Patients not on IcoDextrin will have a variation less than 2 percent and can proceed with the ICU Glycemic Control Protocol. If the patient has a greater than 2 percent variation, the physician will be notified and the ICU Glycemic Control Protocol will be discontinued. Glycemic control will be managed by the physician. If the variation is less than 2 percent the ICU glycemic control protocol will be initiated with variance checked daily thereafter. 3. Pancreas transplant patients Assessment: On admission to the ICU for all patients, the RN will assess and schedule blood glucose reagent strip testing ( fingerstick or IV draw ) according to the following criteria: 1. Group One Patients: Intravenous Glycemic Control: For patients who are NPO (intubated or not), receiving continuous tube feedings or total parenteral nutrition (TPN): blood glucose reagent strip testing and insulin coverage will initially occur every hours. For the first glucose measurement greater than 15 the insulin infusion per nomogram will be started (appendix A). Otherwise glucose testing shall continue every hours. If three in a row glucose values are < 1, blood glucose reagent strip testing can be discontinued by the nurse per protocol. Daily glucose checks through the AM labs will then be used to screen for glucose greater than 15. Page 1 of 1
2 CLINICALPROTOCOL MULTIDISCIPLINARY SECTION: NM NUMBER: 2 HENRY FORD HOSPITAL DETROIT, MICHIGAN TITLE: GLYCEMIC CONTROL INTENSIVE CARE PROTOCOL UNIT: All ICUs APPROVED: 3/3 REVIEWED: REVISED: 12/3, 5/, /, /5, 3/, 11/ For the first glucose value greater than 15, the nurse will initiate the insulin infusion per nomogram (Appendix A). For all initial glucose values 1 to 15, the nurse will administer 2 units of Regular per intravenous push (IVP). If at any time, when checking glucose every hours, the glucose is greater than 15, the insulin infusion per nomogram will be initiated. During the insulin infusion, fingerstick or serum glucose measurements shall be obtained every 2 hours. If the glucose measurement decreases below 1 glucose will be checked every hour until greater than mg/d, at which time every 2 hour monitoring can resume. If glucose measurements are obtained via IV draw, measurements should be drawn from the same site when possible to avoid variance in results. If the insulin drip is turned off for a glucose less than (but greater than ), check glucose every hour until greater than. When the glucose is greater than check every 2 hours. If three in row glucose checks (every 2 hour checks) are less than restart the protocol from the beginning (Change glucose checks to every hours and cover with regular insulin IV push 2 units for glucose 1 to 15 and start the insulin drip for the first glucose greater than 15 ). If all three of the qh checks are between and 1 the glucose can then be checked every 2 hours as part of daily ICU electrolytes with glucose. For patients on the insulin drip: If a patient is diagnosed as insulin sensitive (one or more glucose values less than 1 on the full dose insulin infusion nomogram) the nurse will use the Sensitive Infusion Nomogram for further dose titration. Intravenous Administration - General Considerations and Maintenance infusions will be prepared by Pharmacy as units human regular insulin in ml.9% sodium chloride (concentration: 1 unit/ml). An electronic infusion device will be used to assure proper control of flow rate The IV tubing shall be flushed with ml of the insulin drip solution (1 unit/ml) to saturate all insulin infusion binding sites on the tubing prior to attaching to the patient. will not be withdrawn from the Infusion Solution for purposes of IV push administration. The electronic infusion device controlling the Infusion will not be used to administer bolus doses of insulin. Directions for administering IV push insulin: o o o o o Using an insulin syringe withdraw the required dose of insulin from a vial of Human Regular. Determine which intravenous line will be suitable for administering an intravenous push dose of regular insulin. Use an intravenous line which does not have a continuous infusion of medication already being infused through it (to avoid a bolus of that medication). Flush the intravenous line with 3-5 ml of normal saline. Using the insulin syringe inject the insulin into the injection port. Follow the insulin injection with 3-5 ml of normal saline flush. 2. Group Two Patients: Subcutaneous Glycemic Control for the ICU: For patients who are eating (liquid or solid diet): blood glucose reagent strip testing will be assessed every four hours on this schedule ( ) The, 12, and 1 glucose check should Page 2 of 1
3 CLINICALPROTOCOL MULTIDISCIPLINARY SECTION: NM NUMBER: 2 HENRY FORD HOSPITAL DETROIT, MICHIGAN TITLE: GLYCEMIC CONTROL INTENSIVE CARE PROTOCOL UNIT: All ICUs APPROVED: 3/3 REVIEWED: REVISED: 12/3, 5/, /, /5, 3/, 11/ be before the meal. coverage will start with subcutaneous insulin aspart (Novolog) per level one (see below). When using the glycemic control subcutaneous sliding scale the insulin sensitive level will be started for any of the following: Renal Failure (creatinine greater than 2), Liver Failure, history of insulin sensitivity (one glucose less than 1mg/dl), underweight (weight less than 5kg) or the elderly (age greater than 7 yrs). For two glucose values in a row greater than 15mg/dl at any time increase up one level on the scale to level one from the insulin sensitive level. The following rules will apply to the Subcutaneous Glycemic Control: The nurse will automatically start the glycemic control scale coverage for patients in this group. No special written medications orders are needed except for the glycemic control order on admission to the ICU, unless otherwise determined by the physician. If the first three glucose values in a row are less than 1 glucose checking can be stopped. Start with level one (or insulin sensitive level if indicated). Two glucose values in a row greater than 15 at any time increase up one level on the scale One glucose value at any time less than decrease down one level The 2 (if not a full meal tray consumed), 2 and glucose will only be treated if greater than 15 per current Glycemic Control Scale with a maximum insulin dose of units. NPO: Aspart Dosing: If a patient eating meals or consuming clear liquids becomes NPO (nothing by mouth) the nurse will administer fifty percent (5%) of the dose of aspart insulin. Notify the physician if the glucose decreases below. NPO: Basal Dosing (Glargine or NPH): If a patient eating meals or consuming clear liquids becomes NPO the nurse will administer fifty percent (5%) of the long acting insulin dose (basal insulin dose). If the patient is a Type One Diabetic consult with the physician before changing the dose. Type One diabetics may require their full dose. With a single glucose value greater than 3 mgdl it is generally advised that IV insulin infusion be initiated and the patient be made NPO until 2 consecutive glucose values are less than 15. The nurse will contact the physician to select either the insulin infusion versus the intensification of the Glycemic Control Scale. The RN will document all blood glucose measurements and all insulin documentation on the Intensive Care Glycemic Control Worksheet. Assessment for long acting insulin will be done by the physician (insulin glargine [Lantus] is preferred). Long acting insulin is highly suggested for diabetics or patients on steroids (or others if appropriate). The medication order has to be written by the physician.. Glycemic Control Scales for Group Two Patients Page 3 of 1
4 CLINICALPROTOCOL MULTIDISCIPLINARY SECTION: NM NUMBER: 2 HENRY FORD HOSPITAL DETROIT, MICHIGAN TITLE: GLYCEMIC CONTROL INTENSIVE CARE PROTOCOL UNIT: All ICUs APPROVED: 3/3 REVIEWED: REVISED: 12/3, 5/, /, /5, 3/, 11/ Subcutaneous Glycemic Control Scale for patients on Solid or Liquid Diet Excluding the 2 (if not a full tray consumed), 2, and glucose check (See below table) Blood Glucose Sensitiv e One Two Three Four For Glucose greater than 3, notify the physician for use of the insulin infusion. sensitive level for renal failure (creatinine greater than 2), liver failure, history of insulin sensitivity (one glucose less than 1 ), underweight (weight less than 5 kg), or the elderly (age greater than 7 yrs) Glycemic Control Scale for the 2 (if not a full meal tray), 2, and glucose check Treat only if greater than 15mg/dl with a maximum of units Blood Glucose Sensitiv e One Two Three Four For Glucose greater than 3, notify the physician for use of the insulin infusion. sensitive level for renal failure (creatinine greater than 2), liver failure, history of insulin sensitivity (one glucose less than 1 ), underweight (weight less than 5 kg), or the elderly (age greater than 7 yrs) Page of 1
5 CLINICALPROTOCOL MULTIDISCIPLINARY SECTION: NM NUMBER: 2 HENRY FORD HOSPITAL DETROIT, MICHIGAN TITLE: GLYCEMIC CONTROL INTENSIVE CARE PROTOCOL UNIT: All ICUs APPROVED: 3/3 REVIEWED: REVISED: 12/3, 5/, /, /5, 3/, 11/ Warnings for patients receiving Intravenous or Subcutaneous Glycemic Control (both group one or group two): 1. Hypoglycemia To prevent hypoglycemia: consult physician to start tube feedings, Total Parenteral Nutrition (TPN), or infusion of Dextrose 5%. Hypoglycemia will be treated by the nurse immediately according to the following guidelines: - Glucose 1 give 25 ml of Dextrose 5% (1/2 amp) - Glucose less than 1 give 5 ml of Dextrose 5% ( 1 amp) - If mental status changes caused by hypoglycemia are not reversed, the above dextrose administration will be repeated. - After treatment of hypoglycemia the nurse will notify the physician - The serum glucose will be checked again 1 hour after Dextrose administration. The physician will be notified with the results. Glucose Checks after Hypoglycemia o o o Check Glucose every hour after Dextrose administration until the glucose is greater than mg/dl, then check the glucose every 2 hours. If the glucose continues to be less than mg/dl continue to give Dextrose as above. Restart insulin administration beginning with the SECOND 2 hour glucose check that is greater than mg/dl. If on the insulin drip resume using the insulin sensitive nomogram Previous rate 1 3 units / hr resume at.5 units/hr Previous rate greater than 3 units/hr- resume at 5% of previous rate. If using the glycemic control scales use the Sensitive Scale For patients on the insulin drip (group one patients): If a patient is diagnosed as insulin sensitive (one or more glucose values less than 1 on the full dose insulin infusion nomogram) the nurse will use the Sensitive Infusion Nomogram for further dose titration. For patients receiving aspart insulin per the glycemic control scale (group two patients): One glucose value at any time less than but greater than decrease down one level. For one glucose less than or equal to 1 mg/dl use the Sensitive Scale. 2. Sensitive Patients Group One Patients: The Sensitive Infusion Nomogram will be used for all patients with renal failure (creatinine greater than 2), liver failure, kidney transplant, liver transplant, or insulin sensitivity (one glucose less than 1 mg/dl on the standard nomogram). If a patient is diagnosed as insulin sensitive (one or more glucose values less than 1 on the full dose insulin infusion nomogram) the nurse will use the Sensitive Infusion Nomogram for further dosing. The insulin sensitive nomogram will continued to be used unless otherwise ordered by the physician. Page 5 of 1
6 CLINICALPROTOCOL MULTIDISCIPLINARY SECTION: NM NUMBER: 2 HENRY FORD HOSPITAL DETROIT, MICHIGAN TITLE: GLYCEMIC CONTROL INTENSIVE CARE PROTOCOL UNIT: All ICUs APPROVED: 3/3 REVIEWED: REVISED: 12/3, 5/, /, /5, 3/, 11/ 3. Traveling Patients Group two patients: When using the glycemic control subcutaneous sliding scale the insulin sensitive level will be started should be used for any of the following: Renal Failure (creatinine greater than 2), Liver Failure, history of insulin sensitivity (one glucose less than 1mg/dl), underweight (weight less than 5kg) or the elderly (age greater than 7 yrs). For two glucose values in a row greater than 15mg/dl at any time: increase up one level on the scale to level one from the insulin sensitive level. Group One Patients: For patients traveling off of the unit decrease the insulin infusion by one half and consult with the physician for further insulin drip rate management. Check the patient s glucose on return to the unit and resume the insulin infusion nomogram. Group One Patients: Patient on tube feedings traveling off unit: If the tube feedings are discontinued the insulin drip will be stopped.. Tube Feedings Group One Patients: When tube feedings are discontinued (or temporarily held for any reason) the insulin drip is to be stopped. The glucose will be checked every two hours. The glycemic control protocol can be restarted from the beginning at this point. For glucose values 1 to 15 give 2 units Regular IV push. When the glucose rises above 15 restart the insulin drip. If the glucose remains above 15 and is starting to increase then restart the insulin drip at 2 units/hour (if previous rate was 2 units / hour restart at 1 unit/hour) Group One or Two Patients: Patient on long acting insulin: When tube feedings are held or discontinued the long acting insulin is to be held until the tube feeding is resumed or the long acting insulin is resumed by the physician. (Long acting example: glargine or NPH). If the tube feedings are held after the long acting insulin is given check the glucose every 2 hours for at least checks (12 hours). Call the physician for supplementation with intravenous Dextrose 5% in water for any glucose less than 15. For glucose values between 15 and 2 give 2 units of IV push regular insulin and for the first glucose greater than 2 start the insulin drip per protocol. Group One Patients: Drip and on continuous Tube Feedings: If the patient is on an insulin infusion and at goal with continuous tube feedings for at least 2 hours the nurse or pharmacist should suggest long acting insulin(glargine - Lantus ). This is highly recommended for diabetics or patients on steroids. If the long acting insulin has been administered for at least 3 days and the patients tube feedings have been at goal for at least 2 hours the insulin drip can be discontinued. Every hour glucose testing can start with glycemic control level one (insulin sensitive level if indicated). Subcutaneous aspart insulin can be used unless the patient has edema then regular insulin intravenously (IV push) can be used. If two glucose values in a row are greater than 15 the glycemic control level can be advanced one level. If one glucose value is less than the glycemic control level will be decreased one level. If the patient reaches glycemic control level four and the glucose is greater than 25 the insulin infusion will be restarted. 5. For patients on total parenteral nutrition (TPN) For TPN patients, insulin can be added to the TPN, but only at moderate levels (<5 units/bag) The insulin infusion per nomogram should be used to control glucose in the intensive care unit for glucose values greater than 15. Some patients will be transferred out of the ICU on a TPN and therefore some insulin should be added to the TPN to help for the continuance of glucose control on the general practice unit. Page of 1
7 CLINICALPROTOCOL MULTIDISCIPLINARY SECTION: NM NUMBER: 2 HENRY FORD HOSPITAL DETROIT, MICHIGAN TITLE: GLYCEMIC CONTROL INTENSIVE CARE PROTOCOL UNIT: All ICUs APPROVED: 3/3 REVIEWED: REVISED: 12/3, 5/, /, /5, 3/, 11/ Conversion of Drip to Subcutaneous Glycemic Control For patients started on the insulin infusion, the insulin nomogram will be followed until: 1. the patient is extubated and ready for discharge from the ICU or 2. extubated and started on a liquid or solid diet or 3. on continuous tube feedings at goal for 2 hours and on long acting insulin for at least 3 days (see above Warnings # Tube Feedings) or. The insulin drip per protocol will be continued to control glucose for hours in all cardiothoracic surgery patients (through at least post op day two ). Even if the patient is extubated and started on clear liquids or other diet the insulin drip will be continued per protocol. If the patient is transferred out of the ICU earlier than post op day two the insulin drip can be stopped at the time of discharge. If the patient is still intubated at hours continue the insulin drip per protocol. 5. Otherwise determined by the physician. To help with the conversion off the insulin infusion and preparing for transfer out of the ICU consider starting long acting insulin (insulin glargine-lantus or NPH insulin). The initiation of long acting insulin can be started when the physician deems appropriate (e.g. hemodynamic stability). Adding long acting basal insulin several days before discharge from the ICU will aid in the transition of glycemic control on the general practice unit. This is particularly important in diabetics or patients receiving corticosteroids. This is not an automatic part of the protocol. Consult with the physician for initiating. Steps to Stop Drip: Step #1: Nurse will use aspart insulin for coverage per subcutaneous glycemic control One. Consult physician for long acting insulin (glargine or NPH) if not already prescribed. Step #2: Give long acting insulin (glargine or NPH) Step #3: One hour after giving long acting insulin stop insulin infusion, start glucose checks every 2 hours x then every hours. Cover each glucose per level one of the subcutaneous glycemic control with insulin aspart (Novolog) (for patients ready for transfer to GPU: stop every 2 hr check when ready to transfer and start every hour glucose check on GPU) If no long acting insulin indicated then discontinue drip and check chemstick every 2 hours x then every hours. Use aspart insulin for coverage per subcutaneous glycemic control One. Page 7 of 1
8 CLINICALPROTOCOL MULTIDISCIPLINARY SECTION: NM NUMBER: 2 HENRY FORD HOSPITAL DETROIT, MICHIGAN TITLE: GLYCEMIC CONTROL INTENSIVE CARE PROTOCOL UNIT: All ICUs APPROVED: 3/3 REVIEWED: REVISED: 12/3, 5/, /, /5, 3/, 11/ Extubated and ready for discharge from the ICU. - Suggested Doses for Long Acting Long Acting Dose No History of insulin use at home (and a diabetic or steroid patient) Glargine (Lantus) units Subcutaneous every 2 hours No H/O DM then no glargine needed unless indicated by physician History of use at Home 5% of Home insulin dose as glargine(lantus) subcutaneous every 2 hours or NPH insulin every 12 hours Documentation: Long acting insulin Time (glargine or NPH) Give glargine(lantus) insulin and stop insulin infusion in one hour Give glargine or NPH insulin and stop insulin infusion in one hour Sliding Scale Coverage Start coverage with subcutaneous aspart insulin per One when insulin drip stopped (1 hr after Long acting insulin given): Check Glucose every 2 hours x then every fours until discharge. Start coverage with subcutaneous aspart insulin per One when insulin drip stopped (1 hr after Long acting insulin given): Check Glucose every 2 hours x then every fours until discharge. For all patients admitted to the intensive care unit, the physician shall write in the medication orders ICU Glycemic Control Protocol Document all glucose values and insulin doses on the ICU Glycemic Control Worksheet (Appendix-B). infusion rate adjustments shall also be documented on the ICU flowsheet. References: Zimmerman CR, Mlynarek ME, Jordan JA, Rajda CR, Horst MH. An insulin infusion protocol in critically ill cardiothoracic surgery patients. Ann Pharmacother 2 ;3: july/aug Van Den Berghe G, Wouters P, Weekers F et al. Intensive insulin therapy in critically ill patients. N EnglJ Med. 21; 35: Van Den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2;35:5:9-1 AUTHOR, 2, 2: Mark Mlynarek, R.Ph., BCPS CONSULTANTS, 2, 2: Gail Boleski, RN, CCRN Lisa Cohen, RN Page of 1
9 CLINICALPROTOCOL MULTIDISCIPLINARY SECTION: NM NUMBER: 2 HENRY FORD HOSPITAL DETROIT, MICHIGAN TITLE: GLYCEMIC CONTROL INTENSIVE CARE PROTOCOL UNIT: All ICUs APPROVED: 3/3 REVIEWED: REVISED: 12/3, 5/, /, /5, 3/, 11/ APPROVALS: Yosely Cruz, RN Bruno DiGiovine, M.D. Mattie Horst, M.D. Michael Hudson, M.D. Beth McLellan, RN Princetta Morales, RN Mike Peters, R.Ph., BCPS Dawn Smith, RN Fred Whitehouse, M.D. SICU Committee: 3/25 Executive ICU Committee: 3/2 Critical Care Operations: 3/2, 11/27 Pharmacy & Therapeutic Committee: /2 ICU Clinical Practice: 11//2 Nursing Practice Council: 11//2 Page 9 of 1
10 Appendix A GLYCEMIC CONTROL INSULIN NOMOGRAM <1 INTENSIVE CARE UNIT PATIENTS ONLY Appendix A Group One- Intravenous Infusion- GLYCEMIC CONTROL INSULIN NOMOGRAM <1 INTENSIVE CARE UNIT PATIENTS ONLY GOAL: Glucose levels between -1. Start insulin infusion for 1st value greater than 15 MONITORING: Check glucose Q2h,(either capillary or blood) If Glucose less than check every hour. Restart Q 2 hr blood glucose checks when glucose is greater than. Document all glucose values and dosing on ICU Glycemic Control Worksheet. Guidelines: All Doses are Regular IV 1. Intubated Patients, Not Intubated and NPO, any patient on tube feedings or receiving TPN-Start insulin infusion for 1st value >15 mg/dl. 2. If insulin drip held for glucose less than, restart insulin drip when glucose greater than according to protocol 3. Continue Infusion Protocol until preparing for discharge or otherwise directed by physician.. Consult physician for starting long acting insulin (basal) - glargine ( Lantus) Collaborate with physician or pharmacist about dose. 5. Consult physician to start tube feeding, TPN, or D5W for caloric source and to prevent hypoglycemia. Continue insulin drip protocol. All peritoneal dialysis patients check blood glucose in lab before starting protocol. Make sure blood glucose matches chemstick glucose. 7. If tube feedings are discontinued or held stop the insulin drip- check glucose q2hr restart glycemic control protocol from beginning. Any patient traveling off of the unit, decrease the insulin drip by 5%. Check the glucose on return to the ICU and restart nomogram. STARTING INSULIN INFUSION Glucose >22 Starting Dose Give 2 units Regular insulin IVP and start 2 units/hr If Renal Failure (creatinine >2), Liver Failure, Liver Transplant or Kidney Transplant start at 1 unit/hour Maintenance Drip Glucose Rate 1-3 units/hr < 1 D/C infusion. Give 1 amp Dextrose 5% IVP-Notify Physician. Check glucose hourly until glucose greater than, then every 2 hours. When 2 in a row every 2 hour glucose checks are greater than restart drip at.5 unit/hour and use the insulin sensitive nomogram. Notify physician when glucose greater than 1- D/C infusion. Give 1/2 amp Dextrose 5% IVP-Notify Physician. Check glucose hourly until glucose greater than, then every 2 hours. When 2 in a row every 2 hour glucose checks are greater than restart drip at.5 unit/hour and use the insulin sensitive nomogram. Notify physician when glucose greater than Give units Regular insulin IVP and start units/hr If Renal Failure (creatinine >2), Liver Failure, Liver Transplant, or Kidney Transplant start at 2 units/hour Rate > 3 units/hr D/C infusion. Give 1 amp Dextrose 5% IVP-Notify Physician. Check glucose hourly until glucose greater than, then every 2 hours. When 2 in a row every 2 hour glucose checks are greater than restart drip but reduce rate by 5% and use insulin sensitive nomogram Notify Physician when glucose greater than D/C infusion. Give 1/2 amp Dextrose 5% IVP-Notify Physician. Check glucose hourly until glucose greater than, then every 2 hours. When 2 in a row every 2 hour glucose checks are greater than restart drip but reduce rate by 5% and use insulin sensitive nomogram Notify Physician when glucose greater than 1- Rate 1-3 units/hr D/C Infusion: Recheck glucose EVERY HOUR When glucose greater than restart drip at 1 unit/hr Rate > 3 units/hr D/C Infusion: Re-Check glucose EVERY HOUR. When glucose greater than restart insulin infusion, but decrease dose rate 5% If insulin drip turned off for glucose less than (but greater than ) check every hour until greater than then every 2 hours. If 3 in a row every 2 hour checks are less than restart protocol from beginning. Change glucose check to qh and cover with regular insulin IV push 2 units for glucose 1 to 15 and start insulin drip for first glucose greater than 15. Rate 1-3 units/hr Rate > 3 units/hr 1-1 No Change unless: If previous glucoses higher Reduce drip by 1 unit/hr (If current dose 1 unit / hour do not change) No Change unless: If previous glucose higher then reduce per below: Infusion Rate Decrease Dose by: 7 units/hr 1 unit/hr 12 units/hr 2 units/hr units/hr 3 units/hr 1 22 units/hr units/hr >22 units/hr 5 units/hr Page of 1
11 STANDARD INSULIN NOMOGRAM INSULIN SENSITIVE INFUSION NOMOGRAM Glucose > Dosage All Others Increase Drip Rate by.5 unit/h (no bolus) Continue same rate if Last glucose was higher value Give 2 units Regular insulin IVP and Increase drip rate by 1 u/h Give units Regular insulin IVP and Increase drip rate by 1 u/h Give units Regular insulin IVP and Increase drip rate by 1 u/h Give units Regular insulin IVP and Increase drip rate by 1 u/h Glucose Dosage for: Renal failure-(creatinine > 2), Liver Failure Liver or Kidney Transplant, or one glucose less than 1 mg/dl No Change Give 2 units Regular insulin IVP and Increase drip rate by.5 u/h Give units Regular insulin IVP and Increase drip rate by.5 u/h Give units Regular insulin IVP and Increase drip rate by.5 u/h 31- Give units Regular insulin IVP and Increase drip rate by.5 u/h Call MD for New Order > Call MD for New Order Page 11 of 1
12 Appendix B Group Two Patients- Subcutaneous Glycemic Control Glycemic Control Scales for Group Two Patients Subcutaneous Glycemic Control Scale for patients on Solid or Liquid Diet Excluding the 2 (if not a full tray consumed), 2, and glucose check (see below table) Blood Glucose Sensitive One Two Three Four For Glucose greater than 3 notify the physician for use of the insulin infusion. sensitive level for renal failure (creatinine greater than 2), liver failure, history of insulin sensitivity (one glucose less than 1 ), underweight (weight less than 5 kg), or the elderly (age greater than 7 yrs) 22 Glycemic Control Scale for the 2 (if not a full meal tray), 2, and glucose check Treat only if greater than 15mg/dl with a maximum of units Blood Glucose Sensitive One Two Three Four For Glucose greater than 3 notify the physician for use of the insulin infusion. sensitive level for renal failure (creatinine greater than 2), liver failure, history of insulin sensitivity (one glucose less than 1 ), underweight (weight less than 5 kg), or the elderly (age greater than 7 yrs) Page 12 of 1
13 Hypoglycemia: For Glucose 1- give ½ ampule (25ml) of Dextrose 5% For Glucose < 1 give 1 ampule (5ml) of Dextrose 5% o Check Glucose every hour after Dextrose administration until the glucose is greater than mg/dl, then check the glucose every 2 hours. o Restart insulin administration beginning with the SECOND 2 hour glucose check that is greater than mg/dl. If on the insulin drip resume using the insulin sensitive nomogram Previous rate 1 3 units / hr resume at.5 units/hr Previous rate greater than 3 units/hr- resume at 5% of previous rate. If using the glycemic control scales use the Sensitive Scale Sensitive : For renal failure(creatinine greater than 2), liver failure, history of insulin sensitivity(one previous glucose less than 1 ), underweight (weight less than 5 kg), or elderly (age greater than 7) If on the Sensitive there are two glucose values in a row greater than 15mg/dl at any time: increase up one level on the scale. Approved Uses of Glycemic Scale: 1. Conversion of Drip to Subcutaneous Glycemic Control-continue insulin drip until: a. The patient is extubated and ready for discharge from the ICU or b. Extubated and started on a liquid or solid diet or c. On continuous tube feedings at goal for 2 hours and on long acting insulin for at least three d. All cardiothoracic surgery patients- continue the IV insulin infusion for at least hours- see protocol. 2. Patients who are eating (liquid or solid diet): Blood glucose reagent strip testing will be assessed every four hours on this schedule ( ) The, 12, and 1 glucose check should be before the meal. coverage will start with subcutaneous insulin aspart (Novolog) per level one. The following rules will apply to the Subcutaneous Glycemic Control Scale: The nurse will automatically start the glycemic control scale coverage for patients in this group. No special written medications orders are needed except for the glycemic control order on admission to the ICU. If the first three glucose values in a row are less than 1, glucose checking can be stopped. Start with level one (or insulin sensitive level if indicated). Two glucose values in a row greater than 15 at any time increase up one level on the scale. One glucose value at any time less than decrease down one level. The 2 (if not a full meal tray consumed), 2 and glucose will only be treated if greater than 15 per current Glycemic Control Scale with a maximum insulin dose of units. NPO: Aspart Dosing: If a patient eating meals or consuming clear liquids becomes NPO (nothing by mouth) the nurse will administer fifty percent (5%) of the dose of aspart insulin. Notify the physician if the glucose decreases below. NPO: Basal Dosing (Glargine or NPH): If a patient eating meals or consuming clear liquids becomes NPO the nurse will administer fifty percent (5%) of the long acting insulin dose (basal insulin dose). If the patient is a Type One Diabetic consult with the physician before changing the dose. Type One diabetics may require their full dose. With a single glucose value greater than 3, it is generally advised that IV insulin infusion be initiated and the patient be made NPO until 2 consecutive glucose values are less than 15. The nurse will contact the physician to select either the insulin infusion versus the intensification of the Glycemic Control Scale. Page 13 of 1
14 Assessment for long acting insulin will be done by the physician (insulin glargine [Lantus] is preferred). Long acting insulin is highly suggested for diabetics or patients on steroids (or others if appropriate). The medication order has to be written by the physician. The RN will document all blood glucose measurements and all insulin documentation on the Intensive Care Glycemic Control Worksheet. Page 1 of 1
15 INTENSIVE CARE UNIT GLYCEMIC CONTROL WORKSHEET Appendix C Date: MRN: Name: Guidelines: A. NPO (intubated or not), TPN, continuous Tube Feedings 1. Check glucose every hours x3 on admission to ICU 2. All three glucose values < 1, discontinue checks 3. Any glucose 1 to 15 give 2 units of Regular insulin IV Push. First Glucose greater than 15 start insulin infusion.. Continue Infusion Protocol until preparing for discharge from ICU or otherwise directed by physician. 5. Consult physician for starting long acting insulin (basal) - glargine ( Lantus) or NPH. Collaborate with physician or pharmacist about dose.. If on long acting insulin for 3 days and at goal with continuous tube feedings for 2 hours consider glycemic scale coverage qh 7. Consult physician to start tube feeding, TPN, or D5W for caloric source and to prevent hypoglycemia. B. All Patients on Solid or Liquid Diet (Fork and Knife or drinking from cup) 1. Check glucose every hours on 12-- schedule 2. Use subcutaneous aspart insulin (Novolog) coverage per glycemic control scale. Start with level one or insulin sensitive level if indicated 3. Two glucose values in a row greater than 15, increase up one level (if 1 st 3 in a row<1-stop checks). One glucose value less than decrease one level 5. For pm(if no meal), 12mn and am glucose checks-treat only if glucose greater than 15 dose is per current Glycemic Control Scale with a maximum insulin dose of units. C. Other Guidelines For Glucose 1- give ½ ampule (25ml) of Dextrose 5% For Glucose < 1 give 1 ampule (5ml) of Dextrose 5% Sensitive for renal failure, liver failure, history of insulin sensitivity, or underweight elderly Blood Glucose Regular IV bolus and Drip doses Glycemic Scale For subcutaneous glycemic control Long Acting (BASAL) Date Time Initial Result Regular IV push dose Drip Dose (Units/hr) Date Time Aspart Subcutaneous Dose Time/dose/ Initials of NPH or glargine Initials Name/Professional Designation Initials Name/Professional Designation 11/7 CONTINUE ON OTHER SIDE Page 15 of 1
16 INTENSIVE CARE UNIT GLYCEMIC CONTROL WORKSHEET Date: MRN: Name: Blood Glucose Regular IV bolus and Drip doses Glycemic Scale For subcutaneous glycemic control Long Acting (BASAL) Date Time Initial Result Regular IV push dose Drip Dose (Units/hr) Date Time Aspart Subcutaneous Dose Time/dose/ Initials of NPH or glargine Initials Name/Professional Designation Initials Name/Professional Designation Page 1 of 1
17 INTENSIVE CARE UNIT GLYCEMIC CONTROL WORKSHEET Date: MRN: Name: Guidelines: A. NPO (intubated or not), TPN, continuous Tube Feedings 1. Check glucose every hours x3 on admission to ICU 2. All three glucose values < 1, discontinue checks 3. Any glucose 1 to 15 give 2 units of Regular insulin IV Push. First Glucose greater than 15 start insulin infusion.. Continue Infusion Protocol until preparing for discharge from ICU or otherwise directed by physician. 5. Consult physician for starting long acting insulin (basal) - glargine ( Lantus) or NPH. Collaborate with physician or pharmacist about dose.. If on long acting insulin for 3 days and at goal with continuous tube feedings for 2 hours consider glycemic scale coverage qh 7. Consult physician to start tube feeding, TPN, or D5W for caloric source and to prevent hypoglycemia. B. All Patients on Solid or Liquid Diet (Fork and Knife or drinking from cup) 1. Check glucose every hours on 12-- schedule 2. Use subcutaneous aspart insulin (Novolog) coverage per glycemic control scale. Start with level one or insulin sensitive level if indicated 3. Two glucose values in a row greater than 15, increase up one level (if 1 st 3 in a row<1-stop checks). One glucose value less than decrease one level 5. For pm(if no meal), 12mn and am glucose checks cover with units only if glucose greater than 2 C. Other Guidelines For Glucose 1- give ½ ampule (25ml) of Dextrose 5% For Glucose < 1 give 1 ampule (5ml) of Dextrose 5% Sensitive for renal failure, liver failure, history of insulin sensitivity, or underweight elderly Date Time Blood Glucose Initial Result Regular IV bolus and Drip doses Regular IV push dose Drip Dose (Units/hr) Glycemic Scale For subcutaneous glycemic control Date Time Aspart Subcutaneous Dose Long Acting (BASAL) Time/dose/ Initials of NPH or glargine Initials Name/Professional Designation Initials Name/Professional Designation CONTINUE ON OTHER SIDE Page 17 of 1
18 INTENSIVE CARE UNIT GLYCEMIC CONTROL WORKSHEET Date: MRN: Name: Blood Glucose Date Initial Result Time Regular IV bolus and Drip doses Regular IV push dose Drip Dose (Units/hr) Date Glycemic Scale For subcutaneous glycemic control Time Aspart Subcutaneous Dose Long Acting (BASAL) Time/dose/ Initials of NPH or glargine Initials Name/Professional Designation Initials Name/Professional Designation Page 1 of 1
[ ] POCT glucose Routine, As needed, If long acting insulin is given and patient NPO, do POCT glucose every 2 hours until patient eats.
Glycemic Control - Insulin Infusion NOTE: For treatment of Diabetic Ketoacidosis or Hyperglycemic Hyperosmolar Syndrome please go to order set named Diabetic Ketoacidosis (DKA) and Hyperglycemic Hyperosmolar
More informationCARDIAC SURGERY INTRAVENOUS INSULIN PROTOCOL PHYSICIAN ORDERS INDICATIONS EXCLUSIONS. Insulin allergy
Page 1 of 5 INDICATIONS EXCLUSIONS 2 consecutive blood glucose measurements greater than 110 mg per dl AND NPO with a continuous caloric source AND Diagnosis of : Cardio-thoracic Surgery NOTE: This protocol
More informationDiabetes Management Tube Feeding/Parenteral Nutrition Order Set (Adult)
Review Due Date: 2016 May PATIENT CARE ORDERS Weight (kg) Known Adverse Reactions or Intolerances DRUG No Yes (list) FOOD No Yes (list) LATEX No Yes ***See Suggestions for Management (on reverse)*** ***If
More informationINPATIENT DIABETES MANAGEMENT Robert J. Rushakoff, MD Professor of Medicine Director, Inpatient Diabetes University of California, San Francisco
INPATIENT DIABETES MANAGEMENT Robert J. Rushakoff, MD Professor of Medicine Director, Inpatient Diabetes University of California, San Francisco CLINICAL RECOGNITION Background: Appropriate inpatient glycemic
More information(30251) Insulin SQ Prandial Carbohydrate
Diagnosis Patient MUST BE educated using carbohydrate counting for prial insulin coverage before hospitalization to be eligible for this order set Nursing Metered Glucose (Single Select Section) Metered
More informationKaiser Sunnyside Medical Center Inpatient Pharmacy Manual
Page: 1 of 10 PURPOSE To provide a standard procedure for optimizing care of the inpatient with hyperglycemia and/or diabetes. Substantially provide safe and effective glucose control for all adult inpatients.
More informationat The Valley Hospital (TVH) for Nursing Students/Nursing Instructors 2012
at The Valley Hospital (TVH) for Nursing Students/Nursing Instructors 2012 Subject - Insulin Safety Background Insulin known to be high risk medication Can promote serious hypoglycemia if given incorrectly
More informationImplementing The Portland Protocol - Continuous Intravenous Insulin Infusion in your institution
Implementing The Portland Protocol - Continuous Intravenous Insulin Infusion in your institution Anthony P. Furnary, MD St Vincent Medical Center Providence Health Systems Portland, OR Phased Implementation
More informationManaging the Hospitalized Patient on Insulin: Care Transition. Catie Prinzing MSN, APRN, CNS
Managing the Hospitalized Patient on Insulin: Care Transition Catie Prinzing MSN, APRN, CNS Diabetes and Hospitalization People with DM are hospitalized 3x more frequently than patients without diabetes
More informationA new insulin order form should be completed for subsequent changes to type of insulin and/or frequency of administration
of nurse A new insulin order form should be completed for subsequent changes to type of insulin and/or frequency of administration 1. Check times for point of care meter blood glucose testing. Pre-Breakfast
More informationInpatient Treatment of Diabetes
Inpatient Treatment of Diabetes Alan J. Conrad, MD Medical Director Diabetes Services EVP, Physician Alignment Diabetes Symposium November 12, 2015 Objectives Explain Palomar Health goals for inpatient
More informationTen Ways to Prevent Insulin-Use Errors in Your Hospital. ASHP Research and Education Foundation May 14, 2014
Ten Ways to Prevent Insulin-Use Errors in Your Hospital ASHP Research and Education Foundation May 14, 2014 To Ask Questions and Adjust the Control Panel Expand or Collapse Type your question here Faculty
More informationBASAL BOLUS INSULIN FOR MEDICAL- SURGICAL INPATIENTS
BASAL BOLUS INSULIN FOR MEDICAL- SURGICAL INPATIENTS C O N T A C T D I A B E T E S S E R V I C E S F O R M O R E I N F O R M A T I O N 8 4 7-9 1 7-6 9 0 7 THIS SLIDE PRESENTATION WAS PREPARED BY SUE DROGOS,
More informationSHINE Study Ordering Instructions for Investigators SUNY Downstate
General Directions SHINE Study Ordering Instructions for Investigators SUNY Downstate 1) Call Spiro Demetis to get patient admitted to ICU ASAP. Cell: 646-261-5730; Pager: 917-760-1653. Let him know that
More informationROYAL HOSPITAL FOR WOMEN
ROYAL HOSPITAL FOR WOMEN LOCAL OPERATING PROCEDURE CLINICAL POLICIES, PROCEDURES & GUIDELINES Approved by Quality & Patient Safety Committee 17 April 2014 INSULIN INFUSION PROTOCOL INSULIN DEXTROSE INFUSION
More informationObjectives PERINATAL INSULIN PUMPS: BASICS FOR NURSES. Historical Perspective. Insulin Pumps in Pregnancy. Insulin Pumps in the US
Objectives PERINATAL INSULIN PUMPS: BASICS FOR NURSES Jo M. Kendrick, APN BC, CDE jkendric@utmck.edu Describe indications and contraindications for insulin pump use in hospitalized patients Differentiate
More informationSLIDING SCALE INSULIN ASPART PROTOCOL PLAN
Weight Allergies Patient Care Accucheck Per Sliding Scale Insulin Frequency AC & HS AC & HS 3 days TID BID q12h q6h q6h 24 hr q4h q2h Sliding Scale Insulin Protocol Follow SSI Reference Text Medications
More informationTYPE 2 DIABETES MELLITIS (INSULIN AND/OR METFORMIN) CARE OF WOMEN IN BIRTHING SUITE
TYPE 2 DIABETES MELLITIS (INSULIN AND/OR METFORMIN) CARE OF WOMEN IN BIRTHING SUITE DEFINITION Type 2 Diabetes is characterised by insulin resistance and relative impairment of insulin secretion leading
More informationINTERNAL MEDICINE RESIDENTS NOON CONFERENCE: INPATIENT GLYCEMIC CONTROL
INTERNAL MEDICINE RESIDENTS NOON CONFERENCE: INPATIENT GLYCEMIC CONTROL Presented by: Leyda Callejas PGY5 Endocrinology, Diabetes and Metabolism Acknowledgements: Dr. P Orlander Dr. V Lavis Dr. N Shah
More informationCLASS OBJECTIVES. Describe the history of insulin discovery List types of insulin Define indications and dosages Review case studies
Insulins CLASS OBJECTIVES Describe the history of insulin discovery List types of insulin Define indications and dosages Review case studies INVENTION OF INSULIN 1921 The first stills used to make insulin
More informationManaging the U Managing the U--500 500 Patient as a Surg as a Sur ical Inpatient
Managing the U-500 Patient as a Surgical Inpatient Tyler Fischback Pharmacy Specialist St. Clare Hospital I have no conflicts of interest to disclose The Case DM is a 37 y.o.. developmentally delayed T2DM
More informationIntensive Insulin Therapy in Diabetes Management
Intensive Insulin Therapy in Diabetes Management Lillian F. Lien, MD Medical Director, Duke Inpatient Diabetes Management Assistant Professor of Medicine Division of Endocrinology, Metabolism, & Nutrition
More informationInsulin: A Practice Update. Department of Nursing Staff Development Elizabeth Borgelt, MS, RN
Insulin: A Practice Update Department of Nursing Staff Development Elizabeth Borgelt, MS, RN Learning Outcome The learner will be able to identify the different types of insulins available, their actions,
More informationSARASOTA MEMORIAL HOSPITAL
SARASOTA MEMORIAL HOSPITAL TITLE: NURSING PROCEDURE MANAGEMENT OF PATIENT S OWN INSULIN PUMP/CONTINUOUS SUBCUTANEOUS INSULIN INFUSION PUMP (dia13) DATE: REVIEWED: PAGES: 08/84 10/15 1 of 7 PS1094 ISSUED
More informationSARASOTA MEMORIAL HOSPITAL
SARASOTA MEMORIAL HOSPITAL TITLE: NURSING PROCEDURE CARE OF THE INTRAPARTUM PATIENT RECEIVING CONTINUOUS INTRAVENOUS INSULIN ADMINISTRATION (obs25) DATE: REVIEWED: PAGES: 9/93 8/15 1 of 7 PS1094 ISSUED
More informationObjectives. Clinical Impact of An Inpatient Diabetes Care Model. Impact of Diabetes on Hospitals. The Nebraska Medical Center Stats 6/5/2014
Objectives Clinical Impact of An Inpatient Diabetes Care Model Beth Pfeffer MSN, RN CDE Andjela Drincic, MD 1. Examine the development of the role of the diabetes case manager model in the inpatient setting
More informationPHYSICIAN ORDERS TRANSIENT ISCHEMIC ATTACK (TIA) OBSERVATION
SCREENING- ABCD-2 Score The ABCD2 score is a risk assessment tool designed to improve the prediction of short-term stroke risk after a transient ischemic attack (TIA). Higher ABCD2 scores are associated
More informationGESTATIONAL DIABETES (DIET/INSULIN/METFORMIN) CARE OF WOMEN IN BIRTHING SUITE
GESTATIONAL DIABETES (DIET/INSULIN/METFORMIN) CARE OF WOMEN IN BIRTHING SUITE DEFINITION A disorder characterised by hyperglycaemia first recognised during pregnancy due to increased insulin resistance
More informationIn-hospital management of diabetes
Dr. Tom Elliott MBBS, FRCPC Medical Direct 4102 2775 Laurel St. phone: 604.675.2491 Vancouver, BC fax: 604.875.5931 V5Z 1M9 Canada email: info@bcdiabetes.ca In-hospital management of diabetes General Management
More informationResident s Guide to Inpatient Diabetes
Resident s Guide to Inpatient Diabetes 1. All patients with diabetes of ANY TYPE, regardless of reason for admission, must have a Hemoglobin A1C documented in the medical record within 24 hours of admission
More informationUWMC PRE-OP HOLDING & SURGERY INSULIN INFUSION PROTOCOL Goal Blood Glucose (BG) Range = 80-150 mg/dl. Algorithm 2
V TTG T F G UM - G & UG U FU T Goal Blood Glucose (BG) ange = 80-150 mg/d GTU T M G U/ T TM T. M B lgorithm 1 ecommend start here for type 1 diabetes lgorithm 2 ecommend start here for type 2 diabetes
More informationGlucose Management University of Colorado Hospital
Glucose Management University of Colorado Hospital Bridget Everhart, MSN, NP, CDE Inpatient Diabetes Educator Bridget.Everhart@uch.edu M F Pager 303 266-7898 UCH Diabetes Program Michael McDermott MD Diabetes
More informationObjective. Failure Modes & Effects Analysis: A U-500 Insulin Case Study. What is a FMEA? Assembling a Team. Steps to Conducting a FMEA 5/12/2011
5/12/2011 Objective Failure Modes & Effects Analysis: A U-500 Insulin Case Study Understand the role of a failure mode and effects analysis (FMEA) in developing U-500 insulin use criteria Ryan J. Bickel,
More informationUser guide Basal-bolus Insulin Dosing Chart: Adult
Contacts and further information Local contact Clinical pharmacy or visiting pharmacy Diabetes education service Director of Medical Services Visiting or local endocrinologist or diabetes physician For
More informationContinuous Subcutaneous Insulin Infusion (CSII)
IMPORTANCE OF FOCUS CSII (Insulin pumps) have been used for more than 35 years. In the U.S. in 2005, the level of insulin pump penetration was estimated at 20 to 30% in patients with type 1 diabetes mellitus
More informationEquipment and Supplies Checklist for Parents Student: DOB: School: Grade: Equipment and Supplies to be Provided by Parent. Parent Signature Date
Equipment and Supplies Checklist for Parents Student: DOB: School: Grade: Equipment and Supplies to be Provided by Parent Parent Signature Date Daily Snacks (for AM/PM snack times): Specify: Extra Snacks
More informationA Simplified Approach to Initiating Insulin. 4. Not meeting glycemic goals with oral hypoglycemic agents or
A Simplified Approach to Initiating Insulin When to Start Insulin: 1. Fasting plasma glucose (FPG) levels >250 mg/dl or 2. Glycated hemoglobin (A1C) >10% or 3. Random plasma glucose consistently >300 mg/dl
More informationGlycemic Control Initiative: Insulin Order Set Changes Hypoglycemia Nursing Protocol
Glycemic Control Initiative: Insulin Order Set Changes Hypoglycemia Nursing Protocol Ruth LaCasse Kalish, RPh Department of Pharmacy Objectives Review the current practice at UConn Health with sliding
More informationInsulin Treatment. J A O Hare. www.3bv.org. Bones, Brains & Blood Vessels
Insulin Treatment J A O Hare www.3bv.org Bones, Brains & Blood Vessels Indications for Insulin Treatment Diabetic Ketoacidosis Diabetics with unstable acute illness ICU Gestational Diabetes: diet failure
More informationONCE ONLY GLUCAGON and Fast Acting Glucose gel (PGD) For nurse administration under Patient Group Direction (Trust wide PGD in place)
ADULT INSULIN PRERIPTION AND BLOOD GLUCOSE MONITORING CHART Ward CONSULTANT DATE OF ADMISSION Please affix Patient s label here Ward Ward.../...year PATIENT NAME....... DATE OF BIRTH... NHS NUMBER.......
More informationHospital Guidelines: Inpatient Glycemic Management Guidelines
Hospital Guidelines: Inpatient Glycemic Management Guidelines Reviewed Date: 01/2012 Revision Date: 01/2012 Origination Date: 09/2011 Approved by: Date of Approval: Inpatient Glycemic Control Team 01/2012
More informationClinical Impact of An Inpatient Diabetes Care Model. Objectives
Clinical Impact of An Inpatient Diabetes Care Model Beth Pfeffer MSN, RN CDE June 4, 2014 Objectives 1. Examine the development of the role of the diabetes case manager model in the inpatient setting 2.
More informationDiabetes Expert Witness on: Diabetic Hypoglycemia in Nursing Homes
Diabetes Expert Witness on: Diabetic Hypoglycemia in Nursing Homes Nursing home patients with diabetes treated with insulin and certain oral diabetes medications (i.e. sulfonylureas and glitinides) are
More informationElectronic copy to all appropriate staff Intranet Notification in Staff Focus Related Trust Policies (to be read in conjunction with)
Diabetes Management for Children and Young People undergoing Surgery (0-16 yrs) Clinical Guideline Register No: 10096 Status: Public Developed in response to: Updated national guidelines Contributes to
More informationCSII (CONTINUOUS SUBCUTANEOUS INSULIN INFUSION) AND INPATIENT ADMISSION
CSII (CONTINUOUS SUBCUTANEOUS INSULIN INFUSION) AND INPATIENT ADMISSION Goals of Inpatient Glucose Management Avoid Hypoglycemia (Serum glucose
More informationTypes of insulin and How to Use Them
Diabetes and Insulin Pumps Amy S. Pullen Pharm.D ISHP Spring Meeting April 2012 Objectives Describe the different types of insulin used in diabetes Identify the types of insulin that are compatible with
More informationParenteral Dosage of Drugs
Chapter 11 Parenteral Dosage of Drugs Parenteral Route of administration other than gastrointestinal Intramuscular (IM) Subcutaneous (SC) Intradermal (ID) IV Parenteral Most medications prepared in liquid
More informationOFFICE OF CATHOLIC SCHOOLS DIOCESE OF ARLINGTON DIABETES MEDICAL MANAGEMENT PLAN Page 1 of 5 TO BE COMPLETED BY PARENT OR GUARDIAN
PART I OFFICE OF CATHOLIC SCHOOLS DIOCESE OF ARLINGTON DIABETES MEDICAL MANAGEMENT PLAN Page 1 of 5 TO BE COMPLETED BY PARENT OR GUARDIAN Student School Date of Birth Date of Diagnosis Grade/ Teacher Physical
More informationDiabetes: When To Treat With Insulin and Treatment Goals
Diabetes: When To Treat With Insulin and Treatment Goals Lanita. S. White, Pharm.D. Director, UAMS 12 th Street Health and Wellness Center Assistant Professor of Pharmacy Practice, UAMS College of Pharmacy
More informationDAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES
One Children s Plaza Dayton, OH 45404-1815 www.childrensdayton.org DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended
More informationCalculating Insulin Dose
Calculating Insulin Dose First, some basic things to know about insulin: Approximately 40-50% of the total daily insulin dose is to replace insulin overnight, when you are fasting and between meals. This
More informationInsulin Initiation and Intensification
Insulin Initiation and Intensification ANDREW S. RHINEHART, MD, FACP, CDE MEDICAL DIRECTOR AND DIABETOLOGIST JOHNSTON MEMORIAL DIABETES CARE CENTER Objectives Understand the pharmacodynamics and pharmacokinetics
More informationD( desired ) Q( quantity) X ( amount ) H( have)
Name: 3 (Pickar) Drug Dosage Calculations Chapter 10: Oral Dosage of Drugs Example 1 The physician orders Lasix 40 mg p.o. daily. You have Lasix in 20 mg, 40 mg, and 80 mg tablets. If you use the 20 mg
More informationPeri-Operative Guidelines for Management of Diabetes Patients
Peri-Operative Guidelines for Management of Diabetes Patients Target blood glucose 6-10 mmol/l for all patients Acceptable blood glucose 4-11 mmol/l for all patients Definitions Non-Insulin Glucose Lowering
More informationManagement of Hospital Hyperglycemia
Management of Hospital Hyperglycemia Asad Saeed, M.D. Director, Inpatient Diabetes Assistant Professor of Medicine Division of Endocrinology Department of Medicine University i of Minnesota Outline Clinical
More informationMedications or therapeutic solutions may be injected directly into the bloodstream
Intravenous Therapy Medications or therapeutic solutions may be injected directly into the bloodstream for immediate circulation and use by the body. State practice acts designate which health care professionals
More informationNCT00272090. sanofi-aventis HOE901_3507. insulin glargine
These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription Sponsor/company: Generic drug name:
More informationThere seem to be inconsistencies regarding diabetic management in
Society of Ambulatory Anesthesia (SAMBA) Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery Review of the consensus statement and additional
More informationBLOOD GLUCOSE MONITORING MEDICATION
DIABETES CARE FOR SCHOOL MEDICAL MANAGEMENT PLAN Most Recent A1C and Date: BLOOD GLUCOSE MONITORING Meter Type: Testing Independently: yes no Testing times: Before meals Two hours after insulin dosing
More informationUse of Continuous Subcutaneous Insulin Infusion (CSII) Pumps in Hospitalized Patients Policy and Procedure
Purpose: To ensure safe and accurate administration of insulin for patients using their own external continuous subcutaneous insulin infusion pump during hospitalization. Definitions: Insulin pump: An
More informationMind the Gap: Navigating the Underground World of DKA. Objectives. Back That Train Up! 9/26/2014
Mind the Gap: Navigating the Underground World of DKA Christina Canfield, MSN, RN, ACNS-BC, CCRN Clinical Nurse Specialist Cleveland Clinic Respiratory Institute Objectives Upon completion of this activity
More informationDiabetes and the Elimination of Sliding Scale Insulin. Date: April 30 th 2013. Presenter: Derek Sanders, D.Ph.
Diabetes and the Elimination of Sliding Scale Insulin Date: April 30 th 2013 Presenter: Derek Sanders, D.Ph. Background Information Epidemiology and Risk Factors Diabetes Its Definition and Its Impact
More informationLet s Talk About Meters and Meds. Adapted for Upstate Medical University by: Kristi Shaver, BS, RN, CDE, MS-CNS Student (2014) January 2014
Let s Talk About Meters and Meds Adapted for Upstate Medical University by: Kristi Shaver, BS, RN, CDE, MS-CNS Student (2014) January 2014 How to monitor diabetes control: Hemoglobin A 1 C, or just A 1
More informationBasal and Bolus Insulin 7/16/2014. Jackie Aday RN, BSN, CDE Jeni Neighbors RN, BSN, CDE. BASAL: Small amount of insulin infused every few minutes
Jackie Aday RN, BSN, CDE Jeni Neighbors RN, BSN, CDE Insulin Pump Therapy Open looped system in which a small amount of insulin is continuously infused through a cannula or needle (basal rate) Larger doses
More informationHospital management of diabetes: Beyond the sliding scale
REVIEW CME CREDIT ETIE MOGHISSI, MD Medical Director, Diabetes Care Center at Centinela Hospital, Inglewood, CA; Co-chair, American College of Endocrinology Task Force on Inpatient Diabetes and Metabolic
More informationAddressing safety concerns about U-500 insulin in a hospital setting
Addressing safety concerns about U-500 insulin in a hospital setting Karen Hamrick Samaan, Megan Dahlke, and Judy Stover U-500 regular insulin has been used since the 1950s to treat diabetic patients with
More informationSLIDING SCALE INSULIN REGULAR PLAN
PHYSICIAN S Weight Allergies DETAILS Patient Care POC Blood Sugar Check Per Sliding Scale Insulin Frequency AC & HS AC & HS 3 days TID BID q12h q6h q6h 24 hr q4h q2h Sliding Scale Insulin Regular Guidelines
More informationElectronic Medication Administration Record (emar) (For Cerner Sites Only)
POLICY NO. 1009 Approved: 12/05 Effective: 12/05 Reviewed: 9/10; 5/12 1. Purpose: Electronic Medication Administration Record (emar) (For Cerner Sites Only) To provide direction for the transcription and
More informationHow To Treat A Diabetic Coma With Tpn
GUIDELINES FOR TOTAL PARENTERAL NUTRITION (TPN) IN ADULT BONE MARROW TRANSPLANT PATIENTS TPN Indications TPN is indicated for any patient who is not expected to eat sufficiently for 3-5 days in severe
More informationRecommendations: Other Supportive Therapy of Severe Sepsis*
Recommendations: Other Supportive Therapy of Severe Sepsis* K. Blood Product Administration 1. Once tissue hypoperfusion has resolved and in the absence of extenuating circumstances, such as myocardial
More informationImproving the reporting of Medication Incidents. From Incident Reporting to Controls Assurance
Improving the reporting of Medication Incidents From Incident Reporting to Controls Assurance Quote Strive for perfection in everything you do. Take the best that exists and make it better. When it does
More informationINPATIENT MANAGEMENT OF HYPERGLYCEMIA: THE NORTHWESTERN EXPERIENCE
Original Article INPATIENT MANAGEMENT OF HYPERGLYCEMIA: THE NORTHWESTERN EXPERIENCE Anthony J. DeSantis, MD, 1 Lowell R. Schmeltz, MD, 1 Kathleen Schmidt, MSN, APRN-BC, 1 Eileen O Shea-Mahler, MSN, APRN-BC,
More informationDiabetes Resources. Tamara Meier, APRN-CNS, IBMC Diabetes Specialist. Call ANYTIME for questions! 397-5166
Diabetes Resources Diabetes Specialists Tamara Meier, APRN-CNS, IBMC Diabetes Specialist. Call ANYTIME for questions! 397-5166 Alicia Johnson, APRN-CNP, ISMC Diabetes Specialist. 405.227.4435 Annie L.
More informationDiabetes Mellitus: Type 1
Diabetes Mellitus: Type 1 What is type 1 diabetes mellitus? Type 1 diabetes is a disorder that happens when your body produces little or no insulin. The lack of insulin causes the level of sugar in your
More informationDiabetes and Technology. Disclosures Certified Insulin Pump Trainer for: Animas Medtronic Diabetes Omnipod. Rebecca Ray, MSN, APRN, FNP-C
Diabetes and Technology Rebecca Ray, MSN, APRN, FNP-C Insulin Pump Therapy and Continuous Glucose Monitoring In Patients with Type 2 Diabetes Page 1 Disclosures Certified Insulin Pump Trainer for: Animas
More informationStarting patients on the V-Go Disposable Insulin Delivery Device
Starting patients on the V-Go Disposable Insulin Delivery Device A simple guide for your practice For adult patients with Type 2 diabetes on basal insulin who need to take the next step Identify appropriate
More informationDiabetes Medications: Insulin Therapy
Diabetes Medications: Insulin Therapy Courtesy Univ Texas San Antonio Eric L. Johnson, M.D. Department of Family and Community Medicine Diabetes and Insulin Type 1 Diabetes Autoimmune destruction of beta
More informationReducing the risk of patient harm: A focus on insulin
Reducing the risk of patient harm: A focus on insulin New York State Partnership for Patients (NYSPFP) Initiative Regional Educational Session November 2013 1 1 Disclosure Matt Fricker, Matt Grissinger,
More informationAmarillo Medical Specialists, LLP Endocrinology Division
Amarillo Medical Specialists, LLP Endocrinology Division Technical Notes for use of IV Insulin Drip Protocol William C Biggs, MD FACE updated February 2011 1) Introduction Improved insulin control for
More informationDIABETES MEDICATION INSULIN
Section Three DIABETES MEDICATION INSULIN This section will tell you: About insulin. How to care and store your insulin. When to take your insulin. Different ways of taking insulin. WHAT IS INSULIN? Insulin
More informationChallenges in Glycemic Control in Adult and Geriatric Patients. Denyse Gallagher, APRN-BC, CDE Endocrinology Nurse Practitioner
Challenges in Glycemic Control in Adult and Geriatric Patients Denyse Gallagher, APRN-BC, CDE Endocrinology Nurse Practitioner Provide an overview of diabetes prevalence; discuss challenges and barriers
More informationInsulin Pens & Improving Patient Adherence
Insulin Pens & Improving Patient Adherence Bonnie Pepon, RN, BSN, CDE Certified Diabetes Educator Conemaugh Diabetes Institute Kip Benko, MD FACEP Asst Clinical Professor University of Pittsburgh School
More informationALVIN INDEPENDENT SCHOOL DISTRICT Diabetes Medical Management Plan
ALVIN INDEPENDENT SCHOOL DISTRICT Diabetes Medical Management Plan of Plan: School Year (must be current): This plan should be completed by the student s personal health care team and parents/guardian.
More informationTaking Insulin Pumps to School. Rachel Calendo, MS, RN, CPNP, CDE, Martha Cuevas, RN, BSN, CPT
Taking Insulin Pumps to School Rachel Calendo, MS, RN, CPNP, CDE, Martha Cuevas, RN, BSN, CPT Insulin Pumps Today A micro-computer, about the size of a pager Programmed to deliver both a preset amount
More information2011 EBM-hyperglycemia
嗎 2011 EBM-hyperglycemia 陳 莉 瑋 醫 師 一 定 要 打 打 bolus insulin? 用 FinePrint 列 印 - 可 在 www.ahasoft.com.tw/fineprint 訂 購 Question 1 Is bolus insulin necessary in DKA? P:DKA adult patient I:initial bolus insulin+insulin
More informationBOLUS INSULIN DOSAGES H. Peter Chase, MD and Erin Cobry, BS
CHAPTER 6: BOLUS INSULIN DOSAGES H. Peter Chase, MD and Erin Cobry, BS WHAT IS BOLUS INSULIN? Bolus insulin dosages refer to the quick bursts of insulin given to cover the carbohydrates in meals or snacks
More information4/15/2013. Maribeth Inturrisi RN MS CNS CDE Perinatal Diabetes Educator mbturris@comcast.net
Maribeth Inturrisi RN MS CNS CDE Perinatal Diabetes Educator mbturris@comcast.net List the potential complications associated with diabetes during labor. Identify the 2 most important interventions essential
More informationChapter 2 Subcutaneous Insulin: A Guide for Dosing Regimens in the Hospital
Chapter 2 Subcutaneous Insulin: A Guide for Dosing Regimens in the Hospital Karen Barnard, Bryan C. Batch, and Lillian F. Lien Keywords Basal-bolus insulin Prandial insulin Basal insulin Correction dose
More informationDATE / TIME PROVIDER INITIALS PHYSICIAN ORDERS
If appropriate for this patient, please consider the following order sets: Heart Failure Addendum #609; Acute COPD #789, Glycemic Control - Insulin Infusion #824, Glycemic Control - Subcutaneous Addendum
More informationIntroduction. We hope this guide will aide you and your staff in creating a safe and supportive environment for your students challenged by diabetes.
Introduction Diabetes is a chronic disease that affects the body s ability to metabolize food. The body converts much of the food we eat into glucose, the body s main source of energy. Glucose is carried
More informationThe Importance of Using Insulin Safely. Learning Objectives
The Importance of Using Insulin Safely Victor Tran, PharmD PGY 1 Pharmacy Resident Ambulatory Care Diabetes Symposium November 12, 2015 Learning Objectives List the potential adverse drug events of insulin
More informationThe Joint Commission Advanced DSC Certification for Inpatient Diabetes Care
The Joint Commission Advanced DSC Certification for Inpatient Diabetes Care November 12, 2013 Caroline Isbey RN, MSN, CDE Associate Director Teresa Gomez Associate Project Director Specialist-SSM Carol
More informationType 1 Diabetes Management Based on Glucose Intake www.utmem.edu/endocrinology click Patients (Revised 7/13/2007)
Type 1 Diabetes Management Based on Glucose Intake www.utmem.edu/endocrinology click Patients (Revised 7/13/2007) The following is a system of insulin therapy, diet management, and blood glucose monitoring
More informationYour Road Map to Diabetes Medication Administration Record (Part 1)
Your Road Map to Diabetes Medication dministration Record (Part 1) Ohio Revised ode (3313.713) is the education law that addresses prescriptive medication administration in Ohio schools. This OR lists
More informationPROTOCOL TITLE: Ambulatory Initiation and Management of Warfarin for Adults
PROTOCOL NUMBER: 7 PROTOCOL TITLE: Ambulatory Initiation and Management of Warfarin for Adults THIS PROTOCOL APPLIES TO: UW Health Clinics: all adult outpatients with an active order for warfarin TARGET
More informationDiabetes Management and Treatment Plan for School (For the insulin pump student)
Lafayette School Corporation Health Services Diabetes Management and Treatment Plan for School (For the insulin pump student) Effective Dates: This plan should be complete by the student s personal health
More informationSuffolk County Community College School of Nursing NUR 133 ADULT NURSING I
Suffolk County Community College School of Nursing NUR 133 ADULT NURSING I Page # 1 Instructions for students: Case study # 1 For this lab, you are planning to provide care to the following client: CB
More informationFor Educational Use Only - Not for Detailing or Distribution
This document is intended for healthcare professionals practicing in the United States and may contain information that has not been approved by the FDA. It is supplied to you as a professional courtesy
More informationDiabetes Medical Management Plan (DMMP)
Diabetes Medical Management Plan (DMMP) This plan should be completed by the student s personal diabetes health care team, including the parents/guardian. It should be reviewed with relevant school staff
More informationAndjela Drincic, MD and Marcel Devetten, MD
Andjela Drincic, MD and Marcel Devetten, MD At the completion of this presentation participants should: 1. Know some of the common errors encountered with high-risk medications in the in-patient environment,
More information